Melatonin membrane receptors in peripheral tissues: Distribution and functions

Molecular and Cellular Endocrinology

Volumn 351, Issue 2, 2012, Pages 152-166

  Slominski, Radomir M ^a   Reiter, Russel J ^b   Schlabritz Loutsevitch, Natalia ^a   Ostrom, Rennolds S ^a   Slominski, Andrzej T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Melatonin; Peripheral organs; Receptors; Regulation; Skin

Indexed keywords

ESTROGEN RECEPTOR; FOLLITROPIN; GONADORELIN; HORMONE RECEPTOR; HYDROCORTISONE; LUTEINIZING HORMONE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MELATONIN 3 RECEPTOR; MELATONIN RECEPTOR; NIFEDIPINE; OPIATE RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR; RETINOID RELATED ORPHAN RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR ALPHA2; RETINOID RELATED ORPHAN RECEPTOR BETA; UNCLASSIFIED DRUG;

BONE DEVELOPMENT; BREAST CANCER; BREAST DEVELOPMENT; CIRCADIAN RHYTHM; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; EVENING DOSAGE; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HORMONE STRUCTURE; HUMAN; HYPERTENSION; IMMUNOMODULATION; IMMUNOREGULATION; INTRACELLULAR SIGNALING; MALE TYPE ALOPECIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RENAL PROTECTION; REVIEW; SEASONAL VARIATION; SKIN ATROPHY; SKIN INJURY; SKIN PROTECTION; STEROIDOGENESIS; STOMACH PROTECTION; VASODILATATION; VITILIGO;

ANIMALS; BONE AND BONES; BREAST; CARDIOVASCULAR SYSTEM; DIABETES MELLITUS; FEMALE; GASTROINTESTINAL TRACT; GONADOTROPIN-RELEASING HORMONE; HUMANS; KIDNEY; MELATONIN; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 1; QUINONE REDUCTASES; RECEPTORS, MELATONIN; SKIN; UTERUS;

EID: 84857138170     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.01.004     Document Type: Review

References (251)

1. Abe K., Robison G.A., Liddle G.W., Butcher R.W., Nicholson W.E., Baird C.E. Role of cyclic AMP in mediating the effects of MSH, norepinephrine, and melatonin on frog skin color. Endocrinology 1969, 85:674-682.
2. Anisimov V.N. The role of pineal gland in breast cancer development. Crit. Rev. Oncol. Hematol. 2003, 46:221-234.
3. Anisimov V.N., Ukraintseva S.V., Yashin A.I. Cancer in rodents: does it tell us about cancer in humans?. Nat. Rev. Cancer 2005, 5:807-819.
4. Aoyama H., Mori W., Mori N. Anti-glucocorticoid effects of melatonin in young rats. Acta Pathol. Jpn. 1986, 36:423-428.
5. Arendt J. Melatonin. Clin. Endocrinol. (Oxf). 1988, 29:205-229.
6. Arendt J. Melatonin. BMJ 1996, 312:1242-1243.
7. Ayar A., Kutlu S., Yilmaz B., Kelestimur H. Melatonin inhibits spontaneous and oxytocin-induced contractions of rat myometrium in vitro. Neuroendocrinol. Lett. 2001, 22:199-207.
8. Ayoub M.A., Couturier C., Lucas-Meunier E., Angers S., Fossier P., Bouvier M., Jockers R. Monitoring of ligand-independent dimerization and ligand-induced conformational changes of melatonin receptors in living cells by bioluminescence resonance energy transfer. J. Biol. Chem. 2002, 277:21522-21528.
9. Ayoub M.A., Levoye A., Delagrange P., Jockers R. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers. Mol. Pharmacol. 2004, 66:312-321.
10. Balik A., Kretschmannova K., Mazna P., Svobodova I., Zemkova H. Melatonin action in neonatal gonadotrophs. Physiol. Res. 2004, 53(Suppl. 1):S153-S166.
11. Becker-Andre M., Wiesenberg I., Schaeren-Wiemers N., Andre E., Missbach M., Saurat J.H., Carlberg C. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J. Biol. Chem. 1994, 269:28531-28534.
12. Beskonakli E., Palaoglu S., Aksaray S., Alanoglu G., Turhan T., Taskin Y. Effect of pinealectomy on immune parameters in rats with Staphylococcus aureus infection. Neurosurg. Rev. 2001, 24:26-30.
13. Bitsch F., Aichholz R., Kallen J., Geisse S., Fournier B., Schlaeppi J.M. Identification of natural ligands of retinoic acid receptor-related orphan receptor alpha ligand-binding domain expressed in Sf9 cells - a mass spectrometry approach. Anal. Biochem. 2003, 323:139-149.
14. Boden G., Ruiz J., Urbain J.L., Chen X. Evidence for a circadian rhythm of insulin secretion. Am. J. Physiol. 1996, 271:E246-E252.
15. Borisenkov M.F., Anisimov V.N. Cancer risk in women: a possible connection with geographic and certain economic and social factors. Vopr. Onkol. 2011, 57:343-354.
16. Boutin J.A., Audinot V., Ferry G., Delagrange P. Molecular tools to study melatonin pathways and actions. Trends Pharmacol. Sci. 2005, 26:412-419.
17. Brydon L., Roka F., Petit L., de Coppet P., Tissot M., Barrett P., Morgan P.J., Nanoff C., Strosberg A.D., Jockers R. Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Mol. Endocrinol. 1999, 13:2025-2038.
18. Brzezinski A., Seibel M.M., Lynch H.J., Deng M.H., Wurtman R.J. Melatonin in human preovulatory follicular fluid. J. Clin. Endocrinol. Metab. 1987, 64:865-867.
19. Brzezinski A., Fibich T., Cohen M., Schenker J.G., Laufer N. Effects of melatonin on progesterone production by human granulosa lutein cells in culture. Fertil. Steril. 1992, 58:526-529.
20. Brzozowska I., Ptak-Belowska A., Pawlik M., Pajdo R., Drozdowicz D., Konturek S.J., Pawlik W.W., Brzozowski T. Mucosal strengthening activity of central and peripheral melatonin in the mechanism of gastric defense. J. Physiol. Pharmacol. 2009, 60(Suppl. 7):47-56.
21. Bubenik G.A. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig. Dis. Sci. 2002, 47:2336-2348.
22. Bubenik G.A. Thirty four years since the discovery of gastrointestinal melatonin. J. Physiol. Pharmacol. 2008, 59(Suppl. 2):33-51.
23. Bubenik G.A., Brown G.M., Grota L.J. Immunohistological localization of melatonin in the rat digestive system. Experientia 1977, 33:662-663.
24. Capsoni S., Viswanathan M., De Oliveira A.M., Saavedra J.M. Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis. Endocrinology 1994, 135:373-378.
25. Cardinali D.P., Ladizesky M.G., Boggio V., Cutrera R.A., Mautalen C. Melatonin effects on bone: experimental facts and clinical perspectives. J. Pineal Res. 2003, 34:81-87.
26. Carlberg C., Hooft van Huijsduijnen R., Staple J.K., DeLamarter J.F., Becker-Andre M. RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol. Endocrinol. 1994, 8:757-770.
27. Carrillo-Vico A., Garcia-Perganeda A., Naji L., Calvo J.R., Romero M.P., Guerrero J.M. Expression of membrane and nuclear melatonin receptor mRNA and protein in the mouse immune system. Cell. Mol. Life Sci. 2003, 60:2272-2278.
28. Carrillo-Vico A., Guerrero J.M., Lardone P.J., Reiter R.J. A review of the multiple actions of melatonin on the immune system. Endocrine 2005, 27:189-200.
29. Casao A., Mendoza N., Perez-Pe R., Grasa P., Abecia J.A., Forcada F., Cebrian-Perez J.A., Muino-Blanco T. Melatonin prevents capacitation and apoptotic-like changes of ram spermatozoa and increases fertility rate. J. Pineal Res. 2010, 48:39-46.
30. Celinski K., Konturek S.J., Konturek P.C., Brzozowski T., Cichoz-Lach H., Slomka M., Malgorzata P., Bielanski W., Reiter R.J. Melatonin or l-tryptophan accelerates healing of gastroduodenal ulcers in patients treated with omeprazole. J. Pineal Res. 2011, 50:389-394.
31. Chambers J.C., Zhang W., Zabaneh D., Sehmi J., Jain P., McCarthy M.I., Froguel P., Ruokonen A., Balding D., Jarvelin M.R., Scott J., Elliott P., Kooner J.S. Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians. Diabetes 2009, 58:2703-2708.
32. Chan A.S., Lai F.P., Lo R.K., Voyno-Yasenetskaya T.A., Stanbridge E.J., Wong Y.H. Melatonin mt1 and MT2 receptors stimulate c-Jun N-terminal kinase via pertussis toxin-sensitive and -insensitive G proteins. Cell. Signal. 2002, 14:249-257.
33. Chuffa L.G., Seiva F.R., Favaro W.J., Teixeira G.R., Amorim J.P., Mendes L.O., Fioruci B.A., Pinheiro P.F., Fernandes A.A., Franci J.A., Delella F.K., Martinez M., Martinez F.E. Melatonin reduces LH, 17 beta-estradiol and induces differential regulation of sex steroid receptors in reproductive tissues during rat ovulation. Reprod. Biol. Endocrinol. 2011, 9:108.
34. Cohen M., Lippman M., Chabner B. Role of pineal gland in aetiology and treatment of breast cancer. Lancet 1978, 2:814-816.
35. Cos S., Sánchez-Barceló E.J. Melatonin and mammary pathological growth. Front. Neuroendocrinol. 2000, 21:133-170.
36. Cos S., Gonzalez A., Martinez-Campa C., Mediavilla M.D., Alonso-Gonzalez C., Sanchez-Barcelo E.J. Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions. Cancer Detect. Prev. 2006, 30:118-128.
37. Coto-Montes A., Tomas-Zapico C., Escames G., Leon J., Rodriguez-Colunga M.J., Tolivia D., Acuna-Castroviejo D. Specific binding of melatonin to purified cell nuclei from mammary gland of swiss mice: day-night variations and effect of continuous light. J. Pineal Res. 2003, 34:297-301.
38. Csaba G., Barath P. Morphological changes of thymus and the thyroid gland after postnatal extirpation of pineal body. Endocrinol. Exp. 1975, 9:59-67.
39. Dai J., Ram P.T., Yuan L., Spriggs L.L., Hill S.M. Transcriptional repression of RORalpha activity in human breast cancer cells by melatonin. Mol. Cell. Endocrinol. 2001, 176:111-120.
40. Danforth D.N., Tamarkin L., Lippman M.E. Melatonin increases oestrogen receptor binding activity of human breast cancer cells. Nature 1983, 305:323-325.
41. Dell'anna M.L., Picardo M. A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res. 2006, 19:406-411.
42. Demas G.E., Nelson R.J. Photoperiod and temperature interact to affect immune parameters in adult male deer mice (Peromyscus maniculatus). J. Biol. Rhythms 1996, 11:94-102.
43. Doolen S., Krause D.N., Dubocovich M.L., Duckles S.P. Melatonin mediates two distinct responses in vascular smooth muscle. Eur. J. Pharmacol. 1998, 345:67-69.
44. Drazen D.L., Bilu D., Bilbo S.D., Nelson R.J. Melatonin enhancement of splenocyte proliferation is attenuated by luzindole, a melatonin receptor antagonist. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280:R1476-R1482.
45. 125I]iodomelatonin binding sites correlated with expression of Mel1a and Mel1b receptor genes. J. Endocrinol. 1998, 156:261-267.
46. Dubocovich M.L. Melatonin receptors: are there multiple subtypes?. Trends Pharmacol. Sci. 1995, 16:50-56.
47. Dubocovich M.L., Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005, 27:101-110.
48. Dubocovich M.L., Yun K., Al-Ghoul W.M., Benloucif S., Masana M.I. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J. 1998, 12:1211-1220.
49. Dubocovich M.L., Rivera-Bermudez M.A., Gerdin M.J., Masana M.I. Molecular pharmacology, regulation and function of mammalian melatonin receptors. Front. Biosci. 2003, 8:d1093-d1108.
50. Dubocovich M.L., Hudson R.L., Sumaya I.C., Masana M.I., Manna E. Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse. J. Pineal Res. 2005, 39:113-120.
51. Dubocovich M.L., Delagrange P., Krause D.N., Sugden D., Cardinali D.P., Olcese J. International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol. Rev. 2010, 62:343-380.
52. Ducsay C.A., Yellon S.M. Photoperiod regulation of uterine activity and melatonin rhythms in pregnant rhesus macaque. Biol. Reprod. 1991, 44:967-974.
53. Dufourny L., Levasseur A., Migaud M., Callebaut I., Pontarotti P., Malpaux B., Monget P. GPR50 is the mammalian ortholog of Mel1c: evidence of rapid evolution in mammals. BMC Evol. Biol. 2008, 8:105.
54. Ebisawa T., Karne S., Lerner M.R., Reppert S.M. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc. Natl. Acad. Sci. USA 1994, 91:6133-6137.
55. Esposito T., Magliocca S., Formicola D., Gianfrancesco F. piR_015520 belongs to Piwi-associated RNAs regulates expression of the human melatonin receptor 1A gene. PLoS One 2011, 6:e22727.
56. Esrefoglu M., Seyhan M., Gul M., Parlakpinar H., Batcioglu K., Uyumlu B. Potent therapeutic effect of melatonin on aging skin in pinealectomized rats. J. Pineal Res. 2005, 39:231-237.
57. Facciola G., Hidestrand M., von Bahr C., Tybring G. Cytochrome P450 isoforms involved in melatonin metabolism in human liver microsomes. Eur. J. Clin. Pharmacol. 2001, 56:881-888.
58. Ferry G., Hecht S., Berger S., Moulharat N., Coge F., Guillaumet G., Leclerc V., Yous S., Delagrange P., Boutin J.A. Old and new inhibitors of quinone reductase 2. Chem. Biol. Interact. 2010, 186:103-109.
59. Figueroa J.P., Honnebier M.B., Jenkins S., Nathanielsz P.W. Alteration of 24-h rhythms in myometrial activity in the chronically catheterized pregnant rhesus monkey after a 6-h shift in the light-dark cycle. Am. J. Obstet. Gynecol. 1990, 163:648-654.
60. Fischer T.W., Burmeister G., Schmidt H.W., Elsner P. Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial. Br. J. Dermatol. 2004, 150:341-345.
61. Fischer T.W., Zmijewski M.A., Zbytek B., Sweatman T.W., Slominski R.M., Wortsman J., Slominski A. Oncostatic effects of the indole melatonin and expression of its cytosolic and nuclear receptors in cultured human melanoma cell lines. Int. J. Oncol. 2006, 29:665-672.
62. Fischer T.W., Slominski A., Tobin D.J., Paus R. Melatonin and the hair follicle. J. Pineal Res. 2008, 44:1-15.
63. Fischer T.W., Slominski A., Zmijewski M.A., Reiter R.J., Paus R. Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp. Dermatol. 2008, 17:713-730.
64. Galano A., Tan D.X., Reiter R.J. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J. Pineal Res. 2011, 51:1-16.
65. Ganguly K., Sharma A.V., Reiter R.J., Swarnakar S. Melatonin promotes angiogenesis during protection and healing of indomethacin-induced gastric ulcer: role of matrix metaloproteinase-2. J. Pineal Res. 2010, 49:130-140.
66. Garcia-Maurino S., Gonzalez-Haba M.G., Calvo J.R., Rafii-El-Idrissi M., Sanchez-Margalet V., Goberna R., Guerrero J.M. Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes. J. Immunol. 1997, 159:574-581.
67. Garcia-Maurino S., Pozo D., Calvo J.R., Guerrero J.M. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J. Pineal Res. 2000, 29:129-137.
68. Girgert R., Hanf V., Emons G., Grundker C. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells. J. Pineal Res. 2009, 47:23-31.
69. Girouard H., Chulak C., Lejossec M., Lamontagne D., de Champlain J. Vasorelaxant effects of the chronic treatment with melatonin on mesenteric artery and aorta of spontaneously hypertensive rats. J. Hypertens. 2001, 19:1369-1377.
70. Gomez-Moreno G., Guardia J., Ferrera M.J., Cutando A., Reiter R.J. Melatonin in diseases of the oral cavity. Oral Dis. 2010, 16:242-247.
71. Gorray K.C., Quay W.B. Effects of pinealectomy and of sham-pinealectomy on blood glucose levels in the alloxan-diabetic rat. Horm. Metab. Res. 1978, 10:389-392.
72. Grace M.S., Cahill G.M., Besharse J.C. Melatonin deacetylation: retinal vertebrate class distribution and Xenopus laevis tissue distribution. Brain Res. 1991, 559:56-63.
73. Guerrero J.M., Pozo D., Garcia-Maurino S., Carrillo A., Osuna C., Molinero P., Calvo J.R. Nuclear receptors are involved in the enhanced IL-6 production by melatonin in U937 cells. Biol. Signals Recept. 2000, 9:197-202.
74. Hall R.A., Premont R.T., Lefkowitz R.J. Heptahelical receptor signaling: beyond the G protein paradigm. J. Cell Biol. 1999, 145:927-932.
75. Harbert G.M., Groft B.Y., Spisso K. Effect of biorhythms on blood flow distiribution in the pregnant uterus (Macaca mulatta). Am. J. Obstet. Gynecol. 1979, 135:828-839.
76. Hardeland R., Poeggeler B. Non-vertebrate melatonin. J. Pineal Res. 2003, 34:233-241.
77. Hardeland R., Reiter R.J., Poeggeler B., Tan D.X. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci. Biobehav. Rev. 1993, 17:347-357.
78. Hildebrandt J.D. Role of subunit diversity in signaling by heterotrimeric G proteins. Biochem. Pharmacol. 1997, 54:325-339.
79. Hill S.M., Cheng C., Yuan L., Mao L., Jockers R., Dauchy B., Frasch T., Blask D.E. Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin. Breast Cancer Res. Treat. 2010, 127:91-98.
80. Hirata F., Hayaishi O., Tokuyama T., Seno S. In vitro and in vivo formation of two new metabolites of melatonin. J. Biol. Chem. 1974, 249:1311-1313.
81. Holloway W.R., Grota L.J., Brown G.M. Determination of immunoreactive melatonin in the colon of the rat by immunocytochemistry. J. Histochem. Cytochem. 1980, 28:255-262.
82. Holmes S.W., Sugden D. Proceedings: the effect of melatonin on pinealectomy-induced hypertension in the rat. Br. J. Pharmacol. 1976, 56:360P-361P.
83. Honnebier M.B.O.M., Nathanielsz P.W. Primate parturition and the role of the maternal circadian system. Eur. J. Obstet. Gynecol. Reprod. Biol. 1994, 55:193-203.
84. Honnebier M.B., Jenkins S.L., Wentworth R.A., Figueroa J.P., Nathanielsz P.W. Temporal structuring of delivery in the absence of a photoperiod: preparturient myometrial activity of the rhesus monkey is related to maternal body temperature and depends on the maternal circadian system. Biol. Reprod. 1991, 45:617-625.
85. Houssay A.B., Pazo J.H., Epper C.E. Effects of the pineal gland upon the hair cycles in mice. J. Invest. Dermatol. 1966, 47:230-234.
86. Huang Z., Wells D. The human oocyte and cumulus cells relationship: new insights from the cumulus cell transcriptome. Mol. Hum. Reprod. 2010, 16:715-725.
87. Ibraheem M., Galbraith H., Scaife J., Ewen S. Growth of secondary hair follicles of the Cashmere goat in vitro and their response to prolactin and melatonin. J. Anat. 1994, 185(Pt 1):135-142.
88. Iriti M., Varoni E.M., Vitalini S. Melatonin in traditional Mediterranean diets. J. Pineal Res. 2010, 49:101-105.
89. Iskander K., Paquet M., Brayton C., Jaiswal A.K. Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis. Cancer Res. 2004, 64:5925-5928.
90. Iwasaki S., Nakazawa K., Sakai J., Kometani K., Iwashita M., Yoshimura Y., Maruyama T. Melatonin as a local regulator of human placental function. J. Pineal Res. 2005, 39:261-265.
91. Jaworek J., Nawrot-Porabka K., Leja-Szpak A., Bonior J., Szklarczyk J., Kot M., Konturek S.J., Pawlik W.W. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J. Physiol. Pharmacol. 2007, 58(Suppl. 6):65-80.
92. Jetten A.M. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl. Recept. Signal. 2009, 7:e003.
93. Jockers R., Maurice P., Boutin J.A., Delagrange P. Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?. Br. J. Pharmacol. 2008, 154:1182-1195.
94. Jung-Hynes B., Reiter R.J., Ahmad N. Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J. Pineal Res. 2010, 48:9-19.
95. Kallen J., Schlaeppi J.M., Bitsch F., Delhon I., Fournier B. Crystal structure of the human RORalpha ligand binding domain in complex with cholesterol sulfate at 2.2A. J. Biol. Chem. 2004, 279:14033-14038.
96. Kaneko Y., Hayashi T., Yu S., Tajiri N., Bae E.C., Solomita M.A., Chheda S.H., Weinbren N.L., Parolini O., Borlongan C.V. Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection. J. Pineal Res. 2011, 50:272-280.
97. Kawashima K., Miwa Y., Fujimoto K., Oohata H., Nishino H., Koike H. Antihypertensive action of melatonin in the spontaneously hypertensive rat. Clin. Exp. Hypertens. A 1987, 9:1121-1131.
98. Kim T.H., Jung J.A., Kim G.D., Jang A.H., Ahn H.J., Park Y.S., Park C.S. Melatonin inhibits the development of 2,4-dinitrofluorobenzene-induced atopic dermatitis-like skin lesions in NC/Nga mice. J. Pineal Res. 2009, 47:324-329.
99. Kobayashi Y., Itoh M.T., Kondo H., Okuma Y., Sato S., Kanishi Y., Hamada N., Kiguchi K., Ishizuka B. Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer. J. Pineal Res. 2003, 35:71-74.
100. Kobayashi H., Kromminga A., Dunlop T.W., Tychsen B., Conrad F., Suzuki N., Memezawa A., Bettermann A., Aiba S., Carlberg C., Paus R. A role of melatonin in neuroectodermal-mesodermal interactions: the hair follicle synthesizes melatonin and expresses functional melatonin receptors. FASEB J. 2005, 19:1710-1712.
101. Konturek S.J., Konturek P.C., Brzozowski T. Melatonin in gastroprotection against stress-induced acute gastric lesions and in healing of chronic gastric ulcers. J. Physiol. Pharmacol. 2006, 57(Suppl. 5):51-66.
102. Konturek S.J., Konturek P.C., Brzozowska I., Pawlik M., Sliwowski Z., Czesnikiewicz-Guzik M., Kwiecien S., Brzozowski T., Bubenik G.A., Pawlik W.W. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT). J. Physiol. Pharmacol. 2007, 58:381-405.
103. Konturek S.J., Konturek P.C., Brzozowski T., Bubenik G.A. Role of melatonin in upper gastrointestinal tract. J. Physiol. Pharmacol. 2007, 58(Suppl. 6):23-52.
104. Konturek P.C., Konturek S.J., Burnat G., Brzozowski T., Brzozowska I., Reiter R.J. Dynamic physiological and molecular changes in gastric ulcer healing achieved by melatonin and its precursor l-tryptophan in rats. J. Pineal Res. 2008, 45:180-190.
105. Korkmaz A., Topal T., Tan D.X., Reiter R.J. Role of melatonin in metabolic regulation. Rev. Endocr. Metab. Disord. 2009, 10:261-270.
106. Koyama H., Nakade O., Takada Y., Kaku T., Lau K.H. Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J. Bone Miner. Res. 2002, 17:1219-1229.
107. Krause D.N., Barrios V.E., Duckles S.P. Melatonin receptors mediate potentiation of contractile responses to adrenergic nerve stimulation in rat caudal artery. Eur. J. Pharmacol. 1995, 276:207-213.
108. Kumasaka S., Shimozuma M., Kawamoto T., Mishima K., Tokuyama R., Kamiya Y., Davaadorj P., Saito I., Satomura K. Possible involvement of melatonin in tooth development: expression of melatonin 1a receptor in human and mouse tooth germs. Histochem. Cell Biol. 2010, 133:577-584.
109. Lai L., Yuan L., Chen Q., Dong C., Mao L., Rowan B., Frasch T., Hill S.M. The Galphai and Galphaq proteins mediate the effects of melatonin on steroid/thyroid hormone receptor transcriptional activity and breast cancer cell proliferation. J. Pineal Res. 2008, 45:476-488.
110. Lai L., Yuan L., Cheng Q., Dong C., Mao L., Hill S.M. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Breast Cancer Res. Treat. 2009, 118:293-305.
111. Lang U., Aubert M.L., Conne B.S., Bradtke J.C., Sizonenko P.C. Influence of exogenous melatonin on melatonin secretion and the neuroendocrine reproductive axis of intact male rats during sexual maturation. Endocrinology 1983, 112:1578-1584.
112. Lanoix D., Ouellette R., Vaillancourt C. Expression of melatoninergic receptors in human placental choriocarcinoma cell lines. Hum. Reprod. 2006, 21:1981-1989.
113. Lanoix D., Beghdadi H., Lafond J., Vaillancourt C. Human placental trophoblasts synthesize melatonin and express its receptors. J. Pineal Res. 2008, 45:50-60.
114. Lanoix D., Lacasse A.A., Reiter R.J., Vaillancourt C. Melatonin: the smart killer. The human trophoblast as a model. Mol. Cell. Endocrinol. 2012, 348:1-11.
115. Lee C.K., Kang H.S., Lee B.J., Kang H.M., Choi W.S., Kang S.G. Effects of dopamine and melatonin on the regulation of the PIT-1 isotype, placental growth hormone and lactogen gene expressions in the rat placenta. Mol. Cells 1999, 9:646-651.
116. Lee C.K., Moon D.H., Shin C.S., Kim H., Yoon Y.D., Kang H.S., Lee B.J., Kang S.G. Circadian expression of Mel1a and PL-II genes in placenta: effects of melatonin on the PL-II gene expression in the rat placenta. Mol. Cell. Endocrinol. 2003, 200:57-66.
117. Leja-Szpak A., Jaworek J., Pierzchalski P., Reiter R.J. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J. Pineal Res. 2010, 49:248-255.
118. Lerner A.B. Hormonal control of pigmentation. Annu. Rev. Med. 1960, 11:187-194.
119. Lerner A.B., Case J.D., Mori W., Wright M.R. Melatonin in peripheral nerve. Nature 1959, 183:1821.
120. Lerner A.B., Case J.D., Takahashi Y. Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J. Biol. Chem. 1960, 235:1992-1997.
121. Levoye A., Dam J., Ayoub M.A., Guillaume J.L., Couturier C., Delagrange P., Jockers R. The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization. EMBO J. 2006, 25:3012-3023.
122. Levoye A., Jockers R., Ayoub M.A., Delagrange P., Savaskan E., Guillaume J.L. Are G protein-coupled receptor heterodimers of physiological relevance? Focus on melatonin receptors. Chronobiol. Int. 2006, 23:419-426.
123. Li C., Shi Y., You L., Wang L., Chen Z.J. Association of rs10830963 and rs10830962 SNPs in the melatonin receptor (MTNR1B) gene among Han Chinese women with polycystic ovary syndrome. Mol. Hum. Reprod. 2011, 17:193-198.
124. Lima F.B., Machado U.F., Bartol I., Seraphim P.M., Sumida D.H., Moraes S.M., Hell N.S., Okamoto M.M., Saad M.J., Carvalho C.R., Cipolla-Neto J. Pinealectomy causes glucose intolerance and decreases adipose cell responsiveness to insulin in rats. Am. J. Physiol. 1998, 275:E934-E941.
125. Lindström V., Enetronth P., Swahn M.-L. Diurnal variation of uterine contractility. Br. J. Obstetr. Gynaecol. 1984, 91:155-159.
126. Liu T., Borjigin J. N-Acetyltransferase is not the rate-limiting enzyme of melatonin synthesis at night. J. Pineal Res. 2005, 39:91-96.
127. Lopez-Gonzalez M.A., Calvo J.R., Osuna C., Guerrero J.M. Interaction of melatonin with human lymphocytes: evidence for binding sites coupled to potentiation of cyclic AMP stimulated by vasoactive intestinal peptide and activation of cyclic GMP. J. Pineal Res. 1992, 12:97-104.
128. Lotufo C.M., Lopes C., Dubocovich M.L., Farsky S.H., Markus R.P. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. Eur. J. Pharmacol. 2001, 430:351-357.
129. Lovenberg W., Weissbach H., Udenfriend S. Aromatic l-amino acid decarboxylase. J. Biol. Chem. 1962, 237:89-93.
130. Lovenberg W., Jequier E., Sjoerdsma A. Tryptophan hydroxylation: measurement in pineal gland, brainstem, and carcinoid tumor. Science 1967, 155:217-219.
131. Lusardi P., Preti P., Savino S., Piazza E., Zoppi A., Fogari R. Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects. Blood Press. Monit. 1997, 2:99-103.
132. Lusardi P., Piazza E., Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-h study. Br. J. Clin. Pharmacol. 2000, 49:423-427.
133. Ma X., Idle J.R., Krausz K.W., Gonzalez F.J. Metabolism of melatonin by human cytochromes p450. Drug Metab. Dispos. 2005, 33:489-494.
134. Maestroni G.J., Conti A., Pierpaoli W. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. J. Neuroimmunol. 1986, 13:19-30.
135. Maestroni G.J., Conti A., Pierpaoli W. Role of the pineal gland in immunity. III. Melatonin antagonizes the immunosuppressive effect of acute stress via an opiatergic mechanism. Immunology 1988, 63:465-469.
136. Mahmoud I., Salman S.S., Al-Khateeb A. Continuous darkness and continuous light induce structural changes in the rat thymus. J. Anat. 1994, 185(Pt 1):143-149.
137. Man G.C., Wong J.H., Wang W.W., Sun G.Q., Yeung B.H., Ng T.B., Lee S.K., Ng B.K., Qiu Y., Cheng J.C. Abnormal melatonin receptor 1B expression in osteoblasts from girls with adolescent idiopathic scoliosis. J. Pineal Res. 2011, 50:395-402.
138. Mao L., Yuan L., Slakey L.M., Jones F.E., Burow M.E., Hill S.M. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res. 2010, 12:R107.
139. Masana M.I., Doolen S., Ersahin C., Al-Ghoul W.M., Duckles S.P., Dubocovich M.L., Krause D.N. MT(2) melatonin receptors are present and functional in rat caudal artery. J. Pharmacol. Exp. Ther. 2002, 302:1295-1302.
140. McIsaac W.M., Page I.H. The metabolism of serotonin (5-hydroxytryptamine). J. Biol. Chem. 1959, 234:858-864.
141. Menendez-Pelaez A., Poeggeler B., Reiter R.J., Barlow-Walden L., Pablos M.I., Tan D.X. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J. Cell. Biochem. 1993, 53:373-382.
142. Morgan P.J., Lawson W., Davidson G., Howell H.E. Guanine nucleotides regulate the affinity of melatonin receptors on the ovine pars tuberalis. Neuroendocrinology 1989, 50:359-362.
143. Morgan M.A., Silavin S.L., Wentworth R.A., Figueroa J.P., Honnebier M.B.O.M., Fishburne J.I., Nathanielsz P.W. Different patterns of myometrial activity and 24-h rhythms in myometrial contractility in the gravid baboon during the second half of pregnancy. Biol. Reprod. 1992, 46:1158-1164.
144. Muhlbauer E., Peschke E. Evidence for the expression of both the MT1- and in addition, the MT2-melatonin receptor, in the rat pancreas, islet and beta-cell. J. Pineal Res. 2007, 42:105-106.
145. Myers D.A., Nathanielsz P.W.R. Biological basis of term and preterm labor. Clin. Perinatol. 1993, 20.
146. Nathanielsz P.W. A time to be born: implications of animal studies in maternal-fetal medicine. Birth 1994, 21.
147. Nava M., Romero F., Quiroz Y., Parra G., Bonet L., Rodriguez-Iturbe B. Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats. Am. J. Physiol. Renal Physiol. 2000, 279:F910-F918.
148. Navajas C., Kokkola T., Poso A., Honka N., Gynther J., Laitinen J.T. A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor. Eur. J. Pharmacol. 1996, 304:173-183.
149. Nelson R.J., Demas G.E. Role of melatonin in mediating seasonal energetic and immunologic adaptations. Brain Res. Bull. 1997, 44:423-430.
150. Nelson C.S., Marino J.L., Allen C.N. Melatonin receptors activate heteromeric G-protein coupled Kir3 channels. NeuroReport 1996, 7:717-720.
151. Niles L.P., Wang J., Shen L., Lobb D.K., Younglai E.V. Melatonin receptor mRNA expression in human granulosa cells. Mol. Cell. Endocrinol. 1999, 156:107-110.
152. Nosjean O., Ferro M., Coge F., Beauverger P., Henlin J.M., Lefoulon F., Fauchere J.L., Delagrange P., Canet E., Boutin J.A. Identification of the melatonin-binding site MT3 as the quinone reductase 2. J. Biol. Chem. 2000, 275:31311-31317.
153. Nosjean O., Nicolas J.P., Klupsch F., Delagrange P., Canet E., Boutin J.A. Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2. Biochem. Pharmacol. 2001, 61:1369-1379.
154. Olcese J. Circadian aspects of mammalian parturition: a review. Mol. Cell. Endocrinol. 2011, 349:62-67.
155. Pandi-Perumal S.R., Trakht I., Srinivasan V., Spence D.W., Maestroni G.J., Zisapel N., Cardinali D.P. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog. Neurobiol. 2008, 85:335-353.
156. Panduro-Baron G., Gonzales-Moreno J., Hernandez-Figuerolla E. The biorhythm of birth. Int. J. Gynecol. Obstet. 1994, 45:283-284.
157. Melatonin and Pregnancy 1985, Pergamon Press, Oxford. S.F. Pang, P.L. Tang, G.W.K. Tang, W.C. Yam (Eds.).
158. Paradies G., Petrosillo G., Paradies V., Reiter R.J., Ruggiero F.M. Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J. Pineal Res. 2010, 48:297-310.
159. 125I]iodomelatonin binding sites in Syrian hamster peripheral organs. J. Pharmacol. Exp. Ther. 1999, 290:334-340.
160. Paulis L., Pechanova O., Zicha J., Barta A., Gardlik R., Celec P., Kunes J., Simko F. Melatonin interactions with blood pressure and vascular function during l-NAME-induced hypertension. J. Pineal Res. 2010, 48:102-108.
161. Peschke E. Melatonin, endocrine pancreas and diabetes. J. Pineal Res. 2008, 44:26-40.
162. Peschke E., Fauteck J.D., Musshoff U., Schmidt F., Beckmann A., Peschke D. Evidence for a melatonin receptor within pancreatic islets of neonate rats: functional, autoradiographic, and molecular investigations. J. Pineal Res. 2000, 28:156-164.
163. Picinato M.C., Hirata A.E., Cipolla-Neto J., Curi R., Carvalho C.R., Anhe G.F., Carpinelli A.R. Activation of insulin and IGF-1 signaling pathways by melatonin through MT1 receptor in isolated rat pancreatic islets. J. Pineal Res. 2008, 44:88-94.
164. Pintor J., Martin L., Pelaez T., Hoyle C.H., Peral A. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits. Eur. J. Pharmacol. 2001, 416:251-254.
165. Pozo D., Delgado M., Fernandez-Santos J.M., Calvo J.R., Gomariz R.P., Martin-Lacave I., Ortiz G.G., Guerrero J.M. Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen. FASEB J. 1997, 11:466-473.
166. Quastel M.R., Rahamimoff R. Effect of melatonin on spontaneous contractions and response to 5-hydroxytryptamine of rat isolated duodenum. Br. J. Pharmacol. Chemother. 1965, 24:455-461.
167. Quiroz Y., Ferrebuz A., Romero F., Vaziri N.D., Rodriguez-Iturbe B. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Am. J. Physiol. Renal Physiol. 2008, 294:F336-F344.
168. Ram P.T., Dai J., Yuan L., Dong C., Kiefer T.L., Lai L., Hill S.M. Involvement of the mt1 melatonin receptor in human breast cancer. Cancer Lett. 2002, 179:141-150.
169. Ramracheya R.D., Muller D.S., Squires P.E., Brereton H., Sugden D., Huang G.C., Amiel S.A., Jones P.M., Persaud S.J. Function and expression of melatonin receptors on human pancreatic islets. J. Pineal Res. 2008, 44:273-279.
170. Rasmussen B.M., Christiansen C., Rasmussen O.W., Hansen C., Hermansen K. Alcohol and postexercise metabolic responses in type 2 diabetes. Metabolism 1999, 48:597-602.
171. 125I]-iodomelatonin binding sites in murine mammary tissue. J. Pineal Res. 1994, 16:10-17.
172. Reiter R. Melatonin: that ubiquitously acting pineal hormone. Physiology 1991, 6:223-227.
173. Reiter R.J. Melatonin: the chemical expression of darkness. Mol. Cell. Endocrinol. 1991, 79:C153-C158.
174. Reiter R.J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 1991, 12:151-180.
175. Reiter R.J. The melatonin rhythm: both a clock and a calendar. Experientia 1993, 49:654-664.
176. Reiter R.J., Tan D.X., Qi W., Manchester L.C., Karbownik M., Calvo J.R. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol. Signals Recept. 2000, 9:160-171.
177. Reiter R.J., Tan D.X., Manchester L.C., Pilar Terron M., Flores L.J., Koppisepi S. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv. Med. Sci. 2007, 52:11-28.
178. Reiter R.J., Tan D.X., Fuentes-Broto L. Melatonin: a multitasking molecule. Prog. Brain Res. 2010, 181:127-151.
179. Reppert S.M., Weaver D.R., Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994, 13:1177-1185.
180. Reppert S.M., Godson C., Mahle C.D., Weaver D.R., Slaugenhaupt S.A., Gusella J.F. Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. Proc. Natl. Acad. Sci. USA 1995, 92:8734-8738.
181. Reppert S.M., Weaver D.R., Ebisawa T., Mahle C.D., Kolakowski L.F. Cloning of a melatonin-related receptor from human pituitary. FEBS Lett. 1996, 386:219-224.
182. Reppert S.M., Weaver D.R., Godson C. Melatonin receptors step into the light: cloning and classification of subtypes. Trends Pharmacol. Sci. 1996, 17:100-102.
183. Richter H.G., Torres-Farfan C., Garcia-Sesnich J., Abarzua-Catalan L., Henriquez M.G., Alvarez-Felmer M., Gaete F., Rehren G.E., Seron-Ferre M. Rhythmic expression of functional MT1 melatonin receptors in the rat adrenal gland. Endocrinology 2008, 149:995-1003.
184. Roca A.L., Godson C., Weaver D.R., Reppert S.M. Structure, characterization, and expression of the gene encoding the mouse Mel1a melatonin receptor. Endocrinology 1996, 137:3469-3477.
185. Rodriguez C., Mayo J.C., Sainz R.M., Antolin I., Herrera F., Martin V., Reiter R.J. Regulation of antioxidant enzymes: a significant role for melatonin. J. Pineal Res. 2004, 36:1-9.
186. Rogawski M.A., Roth R.H., Aghajanian G.K. Melatonin: deacetylation to 5-methoxytryptamine by liver but not brain aryl acylamidase. J. Neurochem. 1979, 32:1219-1226.
187. Rogelsperger O., Wlcek K., Ekmekcioglu C., Humpeler S., Svoboda M., Konigsberg R., Klimpfinger M., Jager W., Thalhammer T. Melatonin receptors, melatonin metabolizing enzymes and cyclin D1 in human breast cancer. J. Recept. Signal Transduct. Res. 2011, 31:180-187.
188. Ronnberg L., Kauppila A., Leppaluoto J., Martikainen H., Vakkuri O. Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J. Clin. Endocrinol. Metab. 1990, 71:492-496.
189. Roth J.A., Kim B.G., Lin W.L., Cho M.I. Melatonin promotes osteoblast differentiation and bone formation. J. Biol. Chem. 1999, 274:22041-22047.
190. Roy D., Belsham D.D. Melatonin receptor activation regulates GnRH gene expression and secretion in GT1-7 GnRH neurons. Signal transduction mechanisms. J. Biol. Chem. 2002, 277:251-258.
191. Roy D., Angelini N.L., Fujieda H., Brown G.M., Belsham D.D. Cyclical regulation of GnRH gene expression in GT1-7 GnRH-secreting neurons by melatonin. Endocrinology 2001, 142:4711-4720.
192. Sadowsky D.W., Yellon S., Mitchell M.D., Nathanielsz P.W. Lack of effect of melatonin on myometrial electromyographic activity in the pregnant sheep at 138-142days gestation (term=147days gestation). Endocrinology 1991, 128:1812-1818.
193. Sandyk R., Anastasiadis P.G., Anninos P.A., Tsagas N. Is the pineal gland involved in the pathogenesis of endometrial carcinoma. Int. J. Neurosci. 1992, 62:89-96.
194. Schaeffer H.J., Sirotkin A.V. Melatonin and serotonin directly regulate oxytocin, insulin-like growth factor-I and progesterone secretion by cultured human granulosa cells. Adv. Exp. Med. Biol. 1995, 395:547-548.
195. Schaeffer H.J., Sirotkin A.V. Melatonin and serotonin regulate the release of insulin-like growth factor-I, oxytocin and progesterone by cultured human granulosa cells. Exp. Clin. Endocrinol. Diabetes 1997, 105:109-112.
196. Schallreuter K.U., Wood J.M., Pittelkow M.R., Gutlich M., Lemke K.R., Rodl W., Swanson N.N., Hitzemann K., Ziegler I. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 1994, 263:1444-1446.
197. Schallreuter K.U., Bahadoran P., Picardo M., Slominski A., Elassiuty Y.E., Kemp E.H., Giachino C., Liu J.B., Luiten R.M., Lambe T., Le Poole I.C., Dammak I., Onay H., Zmijewski M.A., Dell'Anna M.L., Zeegers M.P., Cornall R.J., Paus R., Ortonne J.P., Westerhof W. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?. Exp. Dermatol. 2008, 17:139-140. (discussion 141-160).
198. Schlabritz-Loutsevitch N., Hellner N., Middendorf R., Muller D., Olcese J. The human myometrium as a target for melatonin. J. Clin. Endocrinol. Metab. 2003, 88:908-913.
199. Semak I., Naumova M., Korik E., Terekhovich V., Wortsman J., Slominski A. A novel metabolic pathway of melatonin: oxidation by cytochrome C. Biochemistry 2005, 44:9300-9307.
200. Semak I., Korik E., Antonova M., Wortsman J., Slominski A. Metabolism of melatonin by cytochrome P450s in rat liver mitochondria and microsomes. J. Pineal Res. 2008, 45:515-523.
201. Seron-Ferre M., Ducsay C., Valenzuela G.J. Circadian rhythms during pregnancy. Endocr. Rev. 1993, 4:594-608.
202. Sjoblom M., Safsten B., Flemstrom G. Melatonin-induced calcium signaling in clusters of human and rat duodenal enterocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284:G1034-G1044.
203. Slominski A., Pruski D. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp. Cell Res. 1993, 206:189-294.
204. Slominski A., Paus R., Bomirski A. Hypothesis: possible role for the melatonin receptor in vitiligo: discussion paper. J. R. Soc. Med. 1989, 82:539-541.
205. Slominski A., Chassalevris N., Mazurkiewicz J., Maurer M., Paus R. Murine skin as a target for melatonin bioregulation. Exp. Dermatol. 1994, 3:45-50.
206. Slominski A., Pisarchik A., Semak I., Sweatman T., Wortsman J. Characterization of the serotoninergic system in the C57BL/6 mouse skin. Eur. J. Biochem. 2003, 270:3335-3344.
207. Slominski A., Pisarchik A., Wortsman J. Expression of genes coding melatonin and serotonin receptors in rodent skin. Biochim. Biophys. Acta 2004, 1680:67-70.
208. Slominski A., Tobin D.J., Shibahara S., Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol. Rev. 2004, 84:1155-1228.
209. Slominski A., Fischer T.W., Zmijewski M.A., Wortsman J., Semak I., Zbytek B., Slominski R.M., Tobin D.J. On the role of melatonin in skin physiology and pathology. Endocrine 2005, 27:137-148.
210. Slominski A., Wortsman J., Plonka P.M., Schallreuter K.U., Paus R., Tobin D.J. Hair follicle pigmentation. J. Invest. Dermatol. 2005, 124:13-21.
211. Slominski A., Wortsman J., Tobin D.J. The cutaneous serotoninergic/melatoninergic system: securing a place under the sun. FASEB J. 2005, 19:176-194.
212. Slominski A., Tobin D.J., Zmijewski M.A., Wortsman J., Paus R. Melatonin in the skin: synthesis, metabolism and functions. Trends Endocrinol. Metab. 2008, 19:17-24.
213. Smirnov A.N. Nuclear melatonin receptors. Biochemistry (Moscow) 2001, 66:19-26.
214. Soares J.M., Masana M.I., Ersahin C., Dubocovich M.L. Functional melatonin receptors in rat ovaries at various stages of the estrous cycle. J. Pharmacol. Exp. Ther. 2003, 306:694-702.
215. 125I-labelled iodomelatonin-binding sites in the duck kidney. J. Endocrinol. 1992, 135:353-359.
216. Song Y., Chan C.W., Brown G.M., Pang S.F., Silverman M. Studies of the renal action of melatonin: evidence that the effects are mediated by 37kDa receptors of the Mel1a subtype localized primarily to the basolateral membrane of the proximal tubule. FASEB J. 1997, 11:93-100.
217. Stehle J.H., Saade A., Rawashdeh O., Ackermann K., Jilg A., Sebesteny T., Maronde E. A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J. Pineal Res. 2011, 51:17-43.
218. Steinhilber D., Brungs M., Werz O., Wiesenberg I., Danielsson C., Kahlen J.P., Nayeri S., Schrader M., Carlberg C. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J. Biol. Chem. 1995, 270:7037-7040.
219. Suzuki N., Somei M., Kitamura K., Reiter R.J., Hattori A. Novel bromomelatonin derivatives suppress osteoclastic activity and increase osteoblastic activity: implications for the treatment of bone diseases. J. Pineal Res. 2008, 44:326-334.
220. Taketani T., Tamura H., Takasaki A., Lee L., Kizuka F., Tamura I., Taniguchi K., Maekawa R., Asada H., Shimamura K., Reiter R.J., Sugino N. Protective role of melatonin in progesterone production by human luteal cells. J. Pineal Res. 2011, 51:207-213.
221. Tamura H., Nakamura Y., Terron M.P., Flores L.J., Manchester L.C., Tan D.X., Sugino N., Reiter R.J. Melatonin and pregnancy in the human. Reprod. Toxicol. 2008, 25:291-303.
222. Tamura H., Nakamura Y., Korkmaz A., Manchester L.C., Tan D.X., Sugino N., Reiter R.J. Melatonin and the ovary: physiological and pathophysiological implications. Fertil. Steril. 2009, 92:328-343.
223. Tan D.X., Poeggeler B., Reiter R.J., Chen L.D., Chen S., Manchester L.C., Barlow-Walden L.R. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett. 1993, 70:65-71.
224. Tan D.X., Manchester L.C., Reiter R.J., Qi W., Kim S.J., El-Sokkary G.H. Ischemia/reperfusion-induced arrhythmias in the isolated rat heart: prevention by melatonin. J. Pineal Res. 1998, 25:184-191.
225. Tan D.X., Manchester L.C., Reiter R.J., Qi W.B., Karbownik M., Calvo J.R. Significance of melatonin in antioxidative defense system: reactions and products. Biol. Signals Recept. 2000, 9:137-159.
226. Tan D.X., Manchester L.C., Burkhardt S., Sainz R.M., Mayo J.C., Kohen R., Shohami E., Huo Y.S., Hardeland R., Reiter R.J. N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 2001, 15:2294-2296.
227. Tan D.X., Manchester L.C., Hardeland R., Lopez-Burillo S., Mayo J.C., Sainz R.M., Reiter R.J. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J. Pineal Res. 2003, 34:75-78.
228. Tan D.X., Manchester L.C., Terron M.P., Flores L.J., Reiter R.J. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species?. J. Pineal Res. 2007, 42:28-42.
229. Tan D.X., Manchester L.C., Fuentes-Broto L., Paredes S.D., Reiter R.J. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes. Rev. 2011, 12:167-188.
230. Tengattini S., Reiter R.J., Tan D.X., Terron M.P., Rodella L.F., Rezzani R. Cardiovascular diseases: protective effects of melatonin. J. Pineal Res. 2008, 44:16-25.
231. Thor P.J., Krolczyk G., Gil K., Zurowski D., Nowak L. Melatonin and serotonin effects on gastrointestinal motility. J. Physiol. Pharmacol. 2007, 58(Suppl. 6):97-103.
232. Ting K.N., Dunn W.R., Davies D.J., Sugden D., Delagrange P., Guardiola-Lemaitre B., Scalbert E., Wilson V.G. Studies on the vasoconstrictor action of melatonin and putative melatonin receptor ligands in the tail artery of juvenile Wistar rats. Br. J. Pharmacol. 1997, 122:1299-1306.
233. Toma C.D., Svoboda M., Arrich F., Ekmekcioglu C., Assadian O., Thalhammer T. Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors. J. Pineal Res. 2007, 43:206-213.
234. Torres-Farfan C., Richter H.G., Rojas-Garcia P., Vergara M., Forcelledo M.L., Valladares L.E., Torrealba F., Valenzuela G.J., Seron-Ferre M. mt1 Melatonin receptor in the primate adrenal gland: inhibition of adrenocorticotropin-stimulated cortisol production by melatonin. J. Clin. Endocrinol. Metab. 2003, 88:450-458.
235. Torres-Farfan C., Richter H.G., Germain A.M., Valenzuela G.J., Campino C., Rojas-Garcia P., Forcelledo M.L., Torrealba F., Seron-Ferre M. Maternal melatonin selectively inhibits cortisol production in the primate fetal adrenal gland. J. Physiol. 2004, 554:841-856.
236. Treeck O., Haldar C., Ortmann O. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines. Oncol. Rep. 2006, 15:231-235.
237. Vanecek J., Vollrath L. Developmental changes and daily rhythm in melatonin-induced inhibition of 3',5'-cyclic AMP accumulation in the rat pituitary. Endocrinology 1990, 126:1509-1513.
238. Vaughan M.K., Reiter R.J. Transient hypertrophy of the ventral prostate and coagulating glands and accelerated thymic involution following pinealectomy in the mouse. Tex. Rep. Biol. Med. 1971, 29:579-586.
239. Vincent L., Cohen W., Delagrange P., Boutin J.A., Nosjean O. Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand. J. Pineal Res. 2010, 48:222-229.
240. Viswanathan M., Laitinen J.T., Saavedra J.M. Expression of melatonin receptors in arteries involved in thermoregulation. Proc. Natl. Acad. Sci. USA 1990, 87:6200-6203.
241. Vriend J., Lauber J.K. Letter: effects of light intensity, wavelength and quanta on gonads and spleen of the deer mouse. Nature 1973, 244:37-38.
242. Webley G.E., Luck M.R. Melatonin directly stimulates the secretion of progesterone by human and bovine granulosa cells in vitro. J. Reprod. Fertil. 1986, 78:711-717.
243. Webley G.E., Luck M.R., Hearn J.P. Stimulation of progesterone secretion by cultured human granulosa cells with melatonin and catecholamines. J. Reprod. Fertil. 1988, 84:669-677.
244. Weissbach A. A novel system for the incorporation of amino acids by extracts of E. coli B. Biochim. Biophys. Acta 1960, 41:498-509.
245. Wiesenberg I., Missbach M., Kahlen J.P., Schrader M., Carlberg C. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 1995, 23:327-333.
246. Witt-Enderby P.A., Bennett J., Jarzynka M.J., Firestine S., Melan M.A. Melatonin receptors and their regulation: biochemical and structural mechanisms. Life Sci. 2003, 72:2183-2198.
247. Woo M.M., Tai C.J., Kang S.K., Nathwani P.S., Pang S.F., Leung P.C. Direct action of melatonin in human granulosa-luteal cells. J. Clin. Endocrinol. Metab. 2001, 86:4789-4797.
248. Yie S.M., Niles L.P., Younglai E.V. Melatonin receptors on human granulosa cell membranes. J. Clin. Endocrinol. Metab. 1995, 80:1747-1749.
249. Yu H.S., Hernandez V., Haywood M., Wong C.G. Melatonin inhibits the proliferation of retinal pigment epithelial (RPE) cells in vitro. In Vitro Cell. Dev. Biol. Anim. 1993, 29A:415-418.
250. Zanoboni A., Zanoboni-Muciaccia W. Experimental hypertension in pinealectomized rats. Life Sci. 1967, 6:2327-2331.
251. Zhao H., Pang S.F., Poon A.M. Variations of mt1 melatonin receptor density in the rat uterus during decidualization, the estrous cycle and in response to exogenous steroid treatment. J. Pineal Res. 2002, 33:140-145.